You are here: Home / News / U.S. panel narrowly backs Photocure cancer test drug

U.S. panel narrowly backs Photocure cancer test drug

December 17, 2009 By

Related posts:

  1. FDA panel narrowly backs Medtronic spine device
  2. FDA panel backs Pfizer’s drug for kidney cancer
  3. FDA panel backs Pfizer’s drug for kidney cancer
  4. Panel backs stricter blood cancer drug label
  5. FDA panel backs Alexza drug with limits

Filed Under: News Tagged With: ,